Articles published by Pfizer Inc.
![](https://mms.businesswire.com/media/20220524005178/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20220522005063/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20220516005789/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20220510005676/en/1449618/5/Biohaven-Full-Color-Logo.jpg)
![](https://mms.businesswire.com/media/20220502005731/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Pfizer Reports First-Quarter 2022 Results
May 03, 2022
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20220428005422/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Pfizer Declares Second-Quarter 2022 Dividend
April 28, 2022
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20220427005213/en/1433825/5/Biohaven-Full-Color-Logo.jpg)
![](https://mms.businesswire.com/media/20220426005272/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20220419005233/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Pfizer Invites Shareholders to Attend Virtual-Only 2022 Annual Meeting of Shareholders on April 28
April 19, 2022
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20220413006077/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20220411005185/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Pfizer Names David M. Denton Chief Financial Officer
April 11, 2022
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20220407005230/en/1413734/5/ReViral_Colour_Logo.jpg)
![](https://mms.businesswire.com/media/20220328005745/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20220329005198/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20220323005984/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20220323005370/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Pfizer Announces Positive Top-Line Results for Phase 3 Trial of Etrasimod in Ulcerative Colitis Patients
March 23, 2022
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20220322005200/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Pfizer Invites Public to View and Listen to Webcast of May 3 Conference Call with Analysts
March 22, 2022
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20220322005262/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20220228005098/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
February 28, 2022
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20220222005074/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Pfizer Invites Public to View and Listen to Webcast of Pfizer Keynote Presentation at Healthcare Conference
February 22, 2022
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20220214005834/en/1359432/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20220215005838/en/1360218/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20220211005483/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20220209005166/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
February 09, 2022
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20220208005226/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Pfizer Reports Fourth-Quarter and Full-Year 2021 Results
February 08, 2022
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20220201006018/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20220201005136/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Pfizer Announces New Chief Development Officer
February 01, 2022
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20220128005304/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
European Commission Approves LORVIQUA® (lorlatinib) as a First-Line Treatment for ALK-Positive Advanced Lung Cancer
January 28, 2022
From Pfizer Inc.
Via Business Wire
Tickers
PFE
![](https://mms.businesswire.com/media/20220126005886/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
![](https://mms.businesswire.com/media/20220124005896/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg)
Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine in Adults 18 to 55 Years of Age
January 25, 2022
From Pfizer Inc.
Via Business Wire
Tickers
PFE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.